Annenkov A - Search Results

1

Immunotherapy of auto-immune diseases by gene transfer.

Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford L, Baker D, Berenstein M, Podhajcer O. Chernajovsky Y, et al. Among authors: annenkov a. Biochem Soc Trans. 1999 Dec;27(6):869-73. doi: 10.1042/bst0270869. Biochem Soc Trans. 1999. PMID: 10830119 No abstract available.

2

Immuno- and genetic therapy in autoimmune diseases.

Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D, Podhajcer OL, Mageed RA. Chernajovsky Y, et al. Among authors: annenkov a. Genes Immun. 2000 Jun;1(5):295-307. doi: 10.1038/sj.gene.6363683. Genes Immun. 2000. PMID: 11196690 Review.

3

Development of new molecules, vectors and cells for therapy of arthritis.

Chernajovsky Y, Vessillier S, Adams G, Gofur Y, Subang MC, Annenkov A, Favorov P, Daly G, Gould D. Chernajovsky Y, et al. Among authors: annenkov a. Joint Bone Spine. 2003 Dec;70(6):474-6. doi: 10.1016/s1297-319x(03)00157-x. Joint Bone Spine. 2003. PMID: 14667556 No abstract available.

4

Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein.

Annenkov AE, Daly GM, Chernajovsky Y. Annenkov AE, et al. J Gene Med. 2002 Mar-Apr;4(2):133-40. doi: 10.1002/jgm.258. J Gene Med. 2002. PMID: 11933214

5

Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta.

Annenkov A, Chernajovsky Y. Annenkov A, et al. Gene Ther. 2000 Apr;7(8):714-22. doi: 10.1038/sj.gt.3301149. Gene Ther. 2000. PMID: 10800096

6

Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.

Dreja H, Annenkov A, Chernajovsky Y. Dreja H, et al. Among authors: annenkov a. Arthritis Rheum. 2000 Aug;43(8):1698-709. doi: 10.1002/1529-0131(200008)43:8<1698::AID-ANR5>3.0.CO;2-8. Arthritis Rheum. 2000. PMID: 10943859 Free article.

7

Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4(+) T cells is an optimal signal for IFN-gamma production, but not for the production of IL-4.

Annenkov AE, Daly GM, Brocker T, Chernajovsky Y. Annenkov AE, et al. Int Immunol. 2003 May;15(5):665-77. doi: 10.1093/intimm/dxg064. Int Immunol. 2003. PMID: 12697666

8

Gene therapy for rheumatoid arthritis. Theoretical considerations.

Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D. Chernajovsky Y, et al. Among authors: annenkov a. Drugs Aging. 1998 Jan;12(1):29-41. doi: 10.2165/00002512-199812010-00004. Drugs Aging. 1998. PMID: 9467685 Review.

9

Engineering stem cells for therapy.

Mendez-Pertuz M, Hughes C, Annenkov A, Daly G, Chernajovsky Y. Mendez-Pertuz M, et al. Among authors: annenkov a. Regen Med. 2006 Jul;1(4):575-87. doi: 10.2217/17460751.1.4.575. Regen Med. 2006. PMID: 17465851 Review.

10

Latent cytokines for targeted therapy of inflammatory disorders.

Mullen L, Adams G, Layward L, Vessillier S, Annenkov A, Mittal G, Rigby A, Sclanders M, Baker D, Gould D, Chernajovsky Y. Mullen L, et al. Among authors: annenkov a. Expert Opin Drug Deliv. 2014 Jan;11(1):101-10. doi: 10.1517/17425247.2014.863872. Epub 2013 Dec 3. Expert Opin Drug Deliv. 2014. PMID: 24294995 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters